- Home
- ICCC vs NOTE Comparison
ICCC vs NOTE Comparison
Compare ICCC & NOTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCC
- NOTE
- Stock Information
- Founded
- ICCC 1982
- NOTE 2013
- Country
- ICCC United States
- NOTE United States
- Employees
- ICCC N/A
- NOTE N/A
- Industry
- ICCC Biotechnology: Pharmaceutical Preparations
- NOTE EDP Services
- Sector
- ICCC Health Care
- NOTE Technology
- Exchange
- ICCC Nasdaq
- NOTE Nasdaq
- Market Cap
- ICCC 57.4M
- NOTE 65.4M
- IPO Year
- ICCC 1987
- NOTE N/A
- Fundamental
- Price
- ICCC $6.61
- NOTE $5.29
- Analyst Decision
- ICCC
- NOTE Strong Buy
- Analyst Count
- ICCC 0
- NOTE 4
- Target Price
- ICCC N/A
- NOTE $29.25
- AVG Volume (30 Days)
- ICCC 17.1K
- NOTE 271.2K
- Earning Date
- ICCC 11-12-2025
- NOTE 11-11-2025
- Dividend Yield
- ICCC N/A
- NOTE N/A
- EPS Growth
- ICCC N/A
- NOTE N/A
- EPS
- ICCC 0.20
- NOTE N/A
- Revenue
- ICCC $28,274,756.00
- NOTE $109,683,000.00
- Revenue This Year
- ICCC N/A
- NOTE N/A
- Revenue Next Year
- ICCC N/A
- NOTE $41.76
- P/E Ratio
- ICCC $32.15
- NOTE N/A
- Revenue Growth
- ICCC 21.75
- NOTE N/A
- 52 Week Low
- ICCC $3.38
- NOTE $3.80
- 52 Week High
- ICCC $7.60
- NOTE $24.36
- Technical
- Relative Strength Index (RSI)
- ICCC 58.43
- NOTE 68.08
- Support Level
- ICCC $6.30
- NOTE $4.90
- Resistance Level
- ICCC $6.99
- NOTE $5.40
- Average True Range (ATR)
- ICCC 0.30
- NOTE 0.34
- MACD
- ICCC 0.06
- NOTE -0.09
- Stochastic Oscillator
- ICCC 69.06
- NOTE 63.56
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.
About NOTE FiscalNote Holdings Inc.
FiscalNote Holdings Inc is a provider of world-wide policy and market intelligence solutions. Leveraging AI and analytics, it delivers actionable legal and policy insights for businesses, government institutions, and nonprofits. Its suite of products includes FiscalNote Core, CQ Federal, and EU Issue Tracker, facilitating effective policy management and risk mitigation. With its analysis from FrontierView, Oxford Analytica, and Dragonfly Eye, it offers geopolitical and market intelligence services. Operating as one segment, it generates revenue by integrating policy intelligence into daily operations. Geographically the company generates the majority of its revenue from North America, Europe, Australia, and Asia, with the majority generated from North America.